Delivery Order SPE2DB20D2104-SPE2DB23FV37L
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,179.87 for the pharmaceutical product Lantus Solostar 100 unit/ml 3ml. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 16, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $1,975.76 for the supply of Lantus Solostar 100 unit/mL 3mL. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 14, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,940.64 for the pharmaceutical product Lantus Solostar 100 Unit/mL 3mL. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 26, 2022, with a completion date of May 27, 2022. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a delivery order valued at $1,242.64 for the provision of Lantus Solostar 100 unit/mL 3mL medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 29, 2021, with a completion date of September 30, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,187.60 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 5, 2023. The contract is a Firm Fixed Price arrangement and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp, as a major...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a delivery order for the pharmaceutical product Lantus Solostar 100 Unit/ML 3ML. The contract, valued at $2,603.84, was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 8, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FS24B) for Lantus Solostar 100 unit/mL 3mL valued at $1,202.19. The award was made by the Defense Logistics Agency (DLA) on March 29, 2022, with a completion date of March 30, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a $4,832.40 firm fixed-price delivery order placed by the Defense Logistics Agency (DLA) for the pharmaceutical product Lantus Solostar 100 unit/mL 3mL. The contract has an ultimate completion date of May 18, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $2,620.70 Firm Fixed Price Delivery Order for the supply of 4563337065 LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract, awarded by the Defense Logistics Agency (DLA), has a performance period ending on January 17, 2024. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,187.60 firm fixed-price delivery order is for the medical product "LANTUS SOLOSTAR 100 UNIT/ML 3ML" and has an ultimate completion date of August 29, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV37LDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB23FV37L) from the Defense Logistics Agency (DLA) Troop Support Medical for the pharmaceutical product Lantus Solostar 100 Unit/ML 3ML. The $1,187.60 firm-fixed-price contract has a completion date of September 19, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense and Department of Veterans Affairs healthcare programs. The company holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for the provision of a wide range of pharmaceutical products and medical supplies. These IDCs enable the efficient procurement of essential medications, devices, and healthcare commodities to support military, veteran, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/18/23 |